Nortech Systems Names Andrew Walko Senior Vice President of Global Operations

Nortech Systems Incorporated has appointed Andrew Walko as Senior Vice President of Global Operations, effective January 6, 2026. This strategic hiring comes as the company looks to fortify its operations and enhance its value proposition within the complex electromedical and electromechanical market sectors, which include medical imaging, medical devices, industrial, and aerospace & defense. Jay D. Miller, President and CEO of Nortech, expressed confidence in Walko’s leadership abilities, citing his extensive experience in the medical device industry, including previous roles at Sanuwave, Biomerics, and Minnetronix.

Walko will succeed John Lindeen, who is set to retire in the first quarter of 2026. His responsibilities will encompass overseeing Nortech's global operations, including facilities in the U.S., Mexico, and China, as well as managing the global supply chain, new product introductions, production planning, and ensuring timely delivery of products. A key focus for Walko will be to collaborate with customers to enhance lead times, streamline delivery strategies, uphold quality standards, mitigate supply chain risks, and improve cost efficiencies—all vital for Nortech’s long-term growth trajectory.

Nortech has been proactive in diversifying its capabilities through strategic investments, improving efficiencies, and enhancing profitability. The company specializes in complex cable harnesses, printed circuit board assemblies, and system-level assembly, positioning it well for sustained growth in low-volume, high-mix global manufacturing. Headquartered in Maple Grove, Minnesota, Nortech operates six manufacturing locations and design centers across the U.S., Latin America, and Asia, and is listed on NASDAQ under the symbol NSYS.

Nortech Systems Incorporated's recent appointment of Andrew Walko as Senior Vice President of Global Operations is a strategic move that signals a refreshing approach to the company’s operations and growth trajectory. With a rich background in the medical device sector, Walko's expertise could catalyze increased efficiency and enhanced product quality in Nortech's manufacturing processes.

Investors should view this leadership change positively. Walko's experience at prominent companies like Sanuwave and Biomerics, coupled with his operational leadership at Minnetronix, positions him to directly influence Nortech's supply chain dynamics and production strategies. His focus on optimizing the near-shoring strategy and minimizing risk aligns with industry trends favoring localized production to mitigate supply chain disruptions.

Nortech's strategic investments in the U.S., Mexico, and China reflect its commitment to scaling operational efficiencies and expanding market reach. With Walko at the helm, investors can anticipate a stronger emphasis on shorter lead times and tailored customer delivery strategies, which are crucial in the high-demand sectors of medical imaging, aerospace, and industrial markets.

Moreover, Walko's commitment to fostering innovative partnerships will likely enhance Nortech's ability to adapt to customer needs and explore new growth opportunities. This forward-thinking ethos can potentially increase profitability and shareholder value, particularly as healthcare and defense sectors continue to expand.

In the near term, consider watching Nortech’s stock performance closely, particularly during the first quarter as Walko transitions into his new role. It may also be prudent to monitor earnings reports and any insights into operational changes under his leadership. Overall, this appointment represents an undercurrent of positive momentum for Nortech Systems and could yield attractive long-term benefits for investors.